Jubilant Pharmova’s Roorkee unit gets VAI status
FDA has concluded that this inspection is 'closed'
FDA has concluded that this inspection is 'closed'
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
KRKA holds 51% and Laurus Labs holds 49% shareholding
The Product is expected to be the first generic approval on the market
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
 
        Subscribe To Our Newsletter & Stay Updated